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Hemoglobin Concentration and Risk of Cardiovascular Disease 
in Korean Men and Women - The Korean Heart Study 
This study investigated the relationship between hemoglobin concentration and the 
incidence of cardiovascular diseases (CVD). A total of 407,858 subjects (256,851 men, aged 
30-94 yr), who underwent physical examination at 17 Korean nationwide health 
examination centers, was included in this study. Data regarding CVD incidence were 
obtained from the Korean National Health Insurance database. In Cox proportional hazard 
models, men with lower or higher hemoglobin level showed higher hazard ratios (HR) with 
total CVD (HR, 1.14; 95% Confidence interval [CI], 1.08-1.21 for the 1st quintile; HR, 
1.14; 95% CI, 1.09-1.21 for the 5th quintile), ischemic heart disease (HR, 1.16; 95% CI, 
1.07-1.26 for the 1st quintile; HR, 1.16; 95% CI, 1.07-1.25 for the 5th quintile), and 
stroke (HR, 1.13; 95% CI, 1.02-1.25 for the 1st quintile; HR, 1.18; 95% CI, 1.07-1.30 for 
the 5th quintile) compared to those with mid-level of hemoglobin (3rd quintile). Women 
with higher hemoglobin level showed higher HR with total CVD (HR, 1.15; 95% CI,  
1.01-1.31 for pre-menopausal women; HR, 1.08; 95% CI, 1.01-1.16 for post-
menopausal women). We found an independent U-shaped association between 
hemoglobin level and CVD incidence in Korean population.
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ORIGINAL ARTICLE
Cardiovascular Disorders
INTRODUCTION
Cardiovascular disease (CVD) is a leading cause of death world-
wide. In 2011, 7 million people died of ischemic heart disease, 
and 6.2 million from stroke or other forms of cerebrovascular 
disease (1). Cardiovascular death is predicted to increase to ap-
proximately 25 million deaths by 2020, if current trends contin-
ue (2). As well as in developed countries, CVD is becoming a 
greater public health problem in developing countries, particu-
larly in younger people (3). In Korea, about 56,000 people die of 
CVD every year, and it is the second leading cause of death (4). 
While several cardiovascular risk factors such as hypertension, 
smoking, abdominal obesity, abnormal lipids profile, and dia-
betes have been elucidated, these factors cannot fully explain 
all CVD events. Therefore, it is essential to find new cardiovas-
cular risk factors for more effective prevention of CVD.
 Hemoglobin concentration could affect the cardiovascular 
system through oxygen supply and blood viscosity (5). There 
are several studies which assessed the association between he-
moglobin or hematocrit level and CVD. These studies have 
shown that anemia and polycythemia are independent risk fac-
tors of CVD in the general population as well as in patients with 
chronic kidney disease, type 2 diabetes, or polycythemia vera 
(6-10). However, it has not yet been determined whether a he-
moglobin level itself or a hemoglobin level within physiologic 
range has any effect on CVD incidences. Furthermore, only a 
few published studies investigated the relationship between a 
hemoglobin level and CVD incidence in Asian populations 
(11). This study was conducted to determine the relationship 
between hemoglobin level and CVD incidence in a large Kore-
an cohort.
MATERIALS AND METHODS
This study used the database of the Korean Heart Study (KHS). 
KHS was designed for the development of a Korean CVD pre-
diction model. The protocol of KHS has been described in de-
tail elsewhere (12). 
Study population
The population of this study consisted of 476,529 Korean adults 
who underwent health examinations between 1993 and 2004. 
Subjects younger than 30 yr (n = 40,619) and those with a his-
tory of CVD (ischemic heart disease, congestive heart failure, 
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arrhythmia, aortic aneurysm, and stroke) or cancer (n = 23,959) 
were excluded. Subjects without information for hemoglobin 
and those with extreme hemoglobin levels (below 10 g/dL or 
above 20 g/dL) (n = 4,093) were also excluded. Subjects’ medi-
cal history was obtained through self-reported health question-
naire and health insurance reimbursement data. Finally, a total 
of 407,858 subjects (256,851 men) was included in this study. 
Baseline data collection
Baseline parameters of KHS obtained from 17 Korean nation-
wide health examination centers. Smoking status was subdi-
vided into non‐smoker, ex‐smoker, and current smoker. Alco-
hol consumption status was grouped into alcohol drinking (cur-
rent drinking and past drinking) and non‐drinking. Exercise 
status was classified as regular exercise or non-exercise. Hyper-
tension was defined as a systolic blood pressure of at least 140 
mmHg, a diastolic blood pressure of at least 90 mmHg, or tak-
ing antihypertensive medication. Diabetes was defined as self-
reported diagnosis of diabetes or fasting blood glucose levels ≥  
126 mg/dL.
 We analyzed the laboratory data of hemoglobin, fasting glu-
cose, total cholesterol, creatinine, uric acid, and white blood cell 
(WBC) count. For the evaluation of inter-institutional agreement 
of laboratory data, the KHS committee conducted correlation 
analysis of 16 laboratory parameters of each institution using 
the data of the 2006 external quality control examination which 
was conducted by the Korean Association of Quality Assurance 
for Clinical Laboratory. The interlaboratory correlation coeffi-
cients for all laboratory parameters were over 0.95. 
Measurement of outcomes
The outcome variables of this study were the incidences of car-
diovascular diseases. We identified these outcomes from the 
health insurance reimbursement data from the NHIC. CVD was 
defined according to the codes of the International Classifica-
tion of Diseases (ICD), 10th Revision; CVD (I00-I99), ischemic 
heart disease (IHD, I20-I25), acute myocardial infarction (AMI, 
I21), stroke (I60-I69), ischemic stroke (I63), and hemorrhagic 
stroke (I60-I62).
Statistical analysis
All analyses were performed separately for men and women 
because of the gender difference in hemoglobin level. Hemo-
globin level was subdivided into quintiles as follows: I (10-14.4 
g/dL), II (14.5-14.9 g/dL), III (15.0-15.4 g/dL), IV (15.5-16.0 g/
dL), and V (16.1-20 g/dL) for men; and I (10-12.2 g/dL), II (12.3-
12.7 g/dL), III (12.8-13.2 g/dL), IV (13.3-13.7 g/dL), and V (13.8- 
20 g/dL) for women. To examine the differences in cardiovas-
cular risk factors according to the hemoglobin quintiles, the 
age-adjusted general linear model (continuous variables) and 
chi-squared-test (categorical variables) were used. Cox propor-
tional hazards models were used to estimate the independent 
risk of cardiovascular events associated with hemoglobin level. 
Non-adjusted, age-adjusted, and multivariable (age, body mass 
index, total cholesterol, serum creatinine, uric acid, WBC count, 
hypertension, diabetes mellitus, smoking status, alcohol drink-
ing, and regular exercise) adjusted analyses were performed 
with consideration for multicollinearity. Multivariable adjusted 
analyses for subgroups of pre- (< 50 yr) and post-menopausal 
women (≥ 50 yr) were performed. In order to exclude the effect 
of anemia and polycythemia, subgroup analyses for subjects 
with normal hemoglobin levels (13 g/dL ≤ hemoglobin < 18 g/
dL for men, 12 g/dL ≤ hemoglobin < 16 g/dL for women) were 
carried out. These subjects were grouped by hemoglobin level 
with a 1 g/dL interval, and multivariable adjusted Cox’s regres-
sion analyses were performed in men and women. Time de-
pendent Cox’s regression analyses were conducted to investi-
gate whether multivariable-adjusted models satisfied propor-
tional hazards assumptions. All analyses were conducted using 
SAS statistical software version 9.1 (SAS Institute, Cary, NC, USA). 
All statistical tests were two-sided, and statistical significance 
was determined by P < 0.05. 
Ethics statement
The study was approved by the institutional review boards of all 
participating health examination centers.
RESULTS
Baseline characteristics
At baseline, the mean age of the study population was 45.2 ± 9.7 
yr in men and 47.4 ± 10.3 yr in women. The mean hemoglobin 
level in men was higher than in women (15.3 ± 1.1 g/dL vs 13.0 ±  
1.0 g/dL, P < 0.001). 
The relationship between hemoglobin level and 
cardiovascular risk factors 
In men, age was negatively correlated with hemoglobin level, 
while a positive correlation was observed in women. The age-
adjusted general linear models showed that body mass index 
(BMI), blood pressure, fasting glucose, serum total cholesterol, 
creatinine, uric acid, and WBC count were positively correlated 
with hemoglobin level in men and women. Also, hypertension, 
diabetes, and current smoking were more prevalent in subjects 
in upper hemoglobin quintiles (Tables 1, 2). 
Hemoglobin level and cardiovascular risk
During the follow-up period (median 8.2 yr), a total of 30,407 
CVD events (19,049 events in men and 11,358 events in wom-
en) were detected. In men, 8,929 IHD events were detected, and 
1,851 of them were AMI. A total of 5,500 stroke events were de-
tected in men. About 60% of them were of ischemic origin, and 
Kim M-Y, et al. • Hemoglobin Concentration and Cardiovascular Disease
1318  http://jkms.org http://dx.doi.org/10.3346/jkms.2013.28.9.1316
Table 1. Baseline characteristics of the male population according to hemoglobin level
Total
Hemoglobin levels (g/dL)
I 
10-14.4
II 
14.5-14.9
III 
15.0-15.4
IV 
15.5-16.0
V
16.1-20.0
P value‡
Number 256,851 50,965 42,262 51,990 55,166 56,468
Age (yr) 45.2 ± 9.7 47.6 ± 10.6 45.7 ± 9.7 44.8 ± 9.5 44.2 ± 9.3 43.8 ± 9.1 < 0.001
Body mass index (kg/m2) 24.0 ± 2.8 23.0 ± 2.8 23.6 ± 2.7 23.9 ± 2.7 24.3 ± 2.7 24.7 ± 2.8 < 0.001
Systolic BP (mmHg) 122.9 ± 16.4 121.2 ± 17.1 121.7 ± 16.3 122.4 ± 16.0 123.3 ± 16.1 125.2 ± 16.4 < 0.001
Diastolic BP (mmHg) 78.0 ± 11.5 75.8 ± 11.3 76.9 ± 11.2 77.6 ± 11.2 78.6 ± 11.3 80.6 ± 11.6 < 0.001
Fasting glucose (mg/dL) 96.3 ± 23.8 95.2 ± 20.4 95.3 ± 20.4 95.7 ± 21.9 96.3 ± 23.9 98.5 ± 29.5 < 0.001
Total cholesterol (mg/dL) 194.2 ± 34.7 186.4 ± 34.5 191.4 ± 33.7 194.1 ± 34.0 196.8 ± 34.2 200.8 ± 34.9 < 0.001
Creatinine (mg/dL) 1.06 ± 0.24 1.05 ± 0.24 1.05 ± 0.15 1.06 ± 0.40 1.07 ± 0.14 1.08 ± 0.13 < 0.001
Uric acid (mg/dL) 5.8 ± 1.5 5.6 ± 2.0 5.8 ± 1.2 5.9 ± 1.6 5.9 ± 1.2 6.0 ± 1.2 < 0.001
WBC ( × 103/µL) 6.3 ± 1.9 5.9 ± 2.0 6.1 ± 1.9 6.3 ± 1.8 6.5 ± 1.8 6.8 ± 1.9 < 0.001
Hypertension* 72,119 (28.1) 12,346 (24.2) 10,708 (25.4) 13,770 (26.5) 15,929 (28.9) 19,336 (34.3) < 0.001
Diabetes mellitus† 20,474 (8.0) 3,633 (7.1) 2,878 (6.8) 3,771 (7.3) 4,388 (8.0) 5,804 (10.3) < 0.001
Smoking       Current smoker
                    Ex-smoker
                    Non-smoker
135,054 (52.6)
57,645 (22.4)
64,152 (25.0) 
24,257 (47.6)
12,650 (24.8)
14,058 (27.6)
21,135 (50.0)
10,009 (23.7)
11,118 (26.3)
27,010 (52.0)
11,887 (22.9)
13,093 (25.2)
29,774 (54.0)
12,077 (21.9)
13,315 (24.1)
32,878 (58.2)
11,022 (19.5)
12,568 (22.3)
< 0.001
Alcohol drinking 210,084 (81.8) 40,181 (78.8) 34,395 (81.4) 42,722 (82.2) 45,655 (82.8) 47,131 (83.5) < 0.001
Regular exercise 86,088 (49.4) 17,454 (49.4) 14,137 (48.3) 17,480 (49.5) 18,591 (49.9) 18,426 (49.9) < 0.001
Data are presented as mean ± standard deviation for continuous variables, number (%) for categorical variables. *Anti-hypertensive medication, or systolic blood pressure ≥  
140 mmHg or diastolic blood pressure ≥ 90 mmHg; †Diabetes treatment or fasting blood glucose ≥ 126 mg/dL; ‡P values are calculated by the general linear model (continuous 
variables) or chi-squared-test (categorical variables). BP, blood pressure; WBC, White blood cell.  
Table 2. Baseline characteristics of the female population according to hemoglobin level
Total
Hemoglobin levels (g/dL)
I 
10-12.2
II 
12.3-12.7
III 
12.8-13.2
IV 
13.3-13.7
V
13.8-20.0
P value‡
Number 151,007 29,570 26,638 32,874 28,736 33,189
Age (yr) 47.4 ± 10.3 45.5 ± 10.1 46.7 ± 10.3 47.3 ± 10.3 48.1 ± 10.2 49.3 ± 10.2 < 0.001
Body mass index (kg/m2) 23.2 ± 3.1 22.6 ± 2.9 22.9 ± 3.0 23.1 ± 3.0 23.4 ± 3.2 23.9 ± 3.3 < 0.001
Systolic BP (mmHg) 119.7 ± 19.4 115.4 ± 17.7 117.0 ± 18.1 119.2 ± 18.9 121.1 ± 19.5 125.2 ± 20.7 < 0.001
Diastolic BP (mmHg) 74.3 ± 11.9 71.5 ± 11.2 72.5 ± 11.2 74.0 ± 11.6 75.2 ± 11.8 77.9 ± 12.4 < 0.001
Fasting glucose (mg/dL) 93.1 ± 20.3 89.8 ± 13.9 90.6 ± 14.3 91.9 ± 16.3 93.7 ± 19.8 98.7 ± 29.7 < 0.001
Total cholesterol (mg/dL) 194.2 ± 37.2 185.0 ± 35.0 189.5 ± 35.7 193.7 ± 36.5 197.9 ± 37.2 203.5 ± 38.2 < 0.001
Creatinine (mg/dL) 0.81 ± 0.12 0.80 ± 0.14 0.81 ± 0.12 0.81 ± 0.12 0.82 ± 0.12 0.83 ± 0.12 < 0.001
Uric acid (mg/dL) 4.2 ± 1.3 3.9 ± 1.2 4.0 ± 1.5 4.1 ± 0.9 4.2 ± 0.9 4.5 ± 1.7 < 0.001
WBC ( × 103/µL) 5.7 ± 1.7 5.3 ± 1.6 5.5 ± 1.7 5.7 ± 1.5 5.9 ± 1.6 6.2 ± 1.7 < 0.001
Hypertension* 34,972 (23.2) 4,790 (16.2) 4,935 (18.6) 7,155 (21.8) 7,190 (25.1) 10,902 (32.9) < 0.001
Diabetes mellitus† 8,667 (5.7) 1,001 (3.4) 1,012 (3.8) 1,054 (4.6) 1,718 (6.0) 3,432 (10.3) < 0.001
Smoking     Current smoker
                  Ex-smoker
                  Non-smoker
7,255 (4.8)
6,374 (4.2)
137,378 (91.0) 
1,053 (3.6)
1,188 (4.0)
27,329 (92.4)
1,095 (4.1)
1,133 (4.3)
24,410 (91.6)
1,490 (4.5)
1,372 (4.2)
30,012 (91.3)
1,524 (5.3)
1,217 (4.2)
25,995 (90.1)
2,093 (6.3)
1,464 (4.4)
29,632 (89.3)
< 0.001
Alcohol drinking 51,767 (34.3) 9,959 (33.7) 9,242 (34.7) 11,501 (35.0) 9,957 (34.7) 11,108 (33.5) < 0.001
Regular exercise 74,388 (59.5) 14,629 (61.4) 13,219 (60.0) 16,393 (49.5) 14,077 (58.1) 16,070 (58.9) < 0.001
Data are presented as mean ± standard deviation for continuous variables, number (%) for categorical variables. *Anti-hypertensive medication, or systolic blood pres-
sure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg; †Diabetes treatment or fasting blood glucose ≥ 126 mg/dL; ‡P values are calculated by the general linear model 
(continuous variables) or chi-squared-test (categorical variables). BP, blood pressure; WBC, White blood cell.
24% were of hemorrhagic origin. In women, 3,862 IHD events 
were detected, and 471 cases were AMI. A total of 3,425 stroke 
events were detected in women. About 54% of them were of 
ischemic origin, and 24% were of hemorrhagic origin.
 In men, the non-adjusted model showed a U-shape associa-
tion between hemoglobin quintiles and CVD incidences, but 
the age adjusted model showed that only men with upper lev-
els of hemoglobin (4th and 5th quintiles) showed higher hazard 
ratios (HR) with cardiovascular diseases compared to those with 
the mid-level of hemoglobin (3rd quintile). In multivariable ad-
justed model, the 4th and 5th quintiles showed higher HR with 
total CVD (HR, 1.07; 95% confidential interval [CI], 1.01-1.13; 
P = 0.019 for the 4th quintile; HR, 1.14; 95% CI, 1.09-1.21; P <  
0.001 for the 5th quintile) and IHD (HR, 1.09; 95% CI, 1.00-1.18; 
P = 0.039; HR, 1.16, 95% CI, 1.07-1.25; P < 0.001, respectively). 
In addition, the 5th quintile showed higher HR with all stro kes 
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Table 3. Hazard ratios (HR) for cardiovascular disease by hemoglobin quintile in men
Quintiles*
I II III IV V
HR 95% CI HR 95% CI HR HR 95% CI HR 95% CI
Non-adjusted
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
1.29
1.24
1.32
1.41
1.50
1.58
1.23-1.35
1.16-1.33
1.14-1.53
1.30-1.53
1.35-1.67
1.34-1.87
1.05
1.05
1.00
1.13
1.15
1.11
1.00-1.10
0.98-1.13
0.85-1.18
1.03-1.23
1.02-1.29
0.92-1.34
1.0
1.0
1.0
1.0
1.0
1.0
1.07
1.10
1.19
1.04
1.12
1.01
1.02-1.12
1.13-1.17
1.03-1.38
0.96-1.14
1.00-1.25
0.85-1.21
1.20
1.23
1.40
1.16
1.19
1.16
1.14-1.25
1.16-1.31
1.21-1.61
1.07-1.26
1.07-1.33
0.98-1.38
Age-adjusted
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
1.01
1.00
1.04
1.05
1.07
1.26
0.97-1.06
0.94-1.07
0.90-1.21
0.97-1.14
0.96-1.19
1.06-1.49
0.98
0.98
0.94
1.04
1.04
1.04
0.93-1.03
0.92-1.06
0.79-1.10
0.95-1.13
0.92-1.18
0.86-1.25
1.0
1.0
1.0
1.0
1.0
1.0
1.13
1.16
1.26
1.11
1.20
1.07
1.08-1.18
1.08-1.24
1.09-1.46
1.02-1.21
1.07-1.34
0.89-1.28
1.32
1.34
1.52
1.29
1.35
1.26
1.26-1.38
1.25-1.43
1.32-1.75
1.19-1.41
1.21-1.50
1.06-1.50
Multivariable adjusted†
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
1.14
1.16
1.23
1.13
1.17
1.24
1.08-1.21
1.07-1.26
1.03-1.46
1.02-1.25
1.03-1.33
1.01-1.52
1.04
1.04
0.94
1.11
1.13
1.18
0.98-1.10
0.95-1.13
0.78-1.15
0.99-1.23
0.98-1.30
0.95-1.46
1.0
1.0
1.0
1.0
1.0
1.0
1.07
1.09
1.09
1.08
1.13
1.08
1.01-1.13
1.01-1.18
0.91-1.29
0.98-1.20
0.99-1.29
0.87-1.34
1.14
1.16
1.17
1.18
1.19
1.23
1.09-1.21
1.07-1.25
0.99-1.39
1.07-1.30
1.05-1.35
1.00-1.51
Hazard ratios and 95 percent confidence intervals for cardiovascular outcomes were estimated in Cox proportional hazards regression analysis. *The range of hemoglobin quin-
tiles: I (10-14.4 g/dL), II (14.5-14.9 g/dL ), III (15.0-15.4 g/dL), IV (15.5-16.0 g/dL ), and V (16.1-20 g/dL); †Adjusted for age, body mass index, total cholesterol, serum creati-
nine, uric acid, WBC count, hypertension, diabetes mellitus, smoking status, alcohol drinking, and regular exercise. HR, hazard ratio; CI, confidence interval; CVD, cardiovascular 
disease; IHD, ischemic heart disease; AMI, acute myocardial infarction. 
Fig. 1. Hazard ratios for total cardiovascular disease (CVD), ischemic heart disease 
(IHD), and stroke according to hemoglobin levels within the normal range in men The 
reference category was a hemoglobin level of 15.0 g/dL to 15.9 g/dL. All hazard ra-
tios were adjusted for age, body mass index, total cholesterol, serum creatinine, uric 
acid, WBC count, hypertension, diabetes mellitus, smoking status, alcohol drinking, 
and regular exercise *P < 0.05.
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(HR, 1.18; 95% CI, 1.07-1.30; P = 0.001) and ischemic stroke (HR, 
1.19; 95% CI, 1.05-1.35; P = 0.009) compared to the 3rd quintile. 
The lowest hemoglobin level (1st quintile) also showed higher 
HR with total CVD (HR, 1.14; 95% CI, 1.08-1.21; P < 0.001), IHD 
(HR, 1.16; 95% CI, 1.07-1.26; P < 0.001), AMI (HR, 1.23; 95% CI, 
1.03-1.46; P = 0.021), all strokes (HR, 1.13; 95% CI, 1.02 -1.25; 
P = 0.018), ischemic stroke (HR, 1.17; 95% CI, 1.03-1.33; 
P = 0.016), and hemorrhagic stroke (HR, 1.24; 95% CI, 1.01-1.52; 
P = 0.041) compared to the 3rd quintile (Table 3). Men with a 
normal hemoglobin level also showed a U-shape association 
between hemoglobin level and total CVD incidence (Fig. 1).
 In women, non-adjusted model showed a positive correla-
tion between hemoglobin level and all CVD incidences. In the 
multivariable adjusted model, the 5th quintile showed higher 
HR with total CVD in both pre- and post-menopausal women 
compared to the 3rd quintile (HR, 1.15; 95% CI, 1.01-1.31; P =  
0.041 for pre-menopausal women, HR, 1.08; 95% CI, 1.01-1.16; 
P = 0.036 for post-menopausal women) (Table 4). However, 
women with a normal hemoglobin level did not show any sig-
nificant association between hemoglobin level and CVD inci-
dence (data not shown). 
 Time dependent Cox’s regression analyses showed that every 
Cox proportional hazard model satisfied the proportional haz-
ards assumptions.
DISCUSSION
In the early 1980s, some studies reported that high hemoglobin 
or hematocrit could be a risk factor of IHD in men but not in 
women, but they did not consider the currently well-known 
cardiovascular risk factors (11, 13). Thereafter, the Framingham 
Heart Study, which had followed approximately 5,200 people 
for 34 yr, reported the relationship between hematocrit and 
CVD incidence in women after adjusting for multiple cardio-
vascular risk factors (14). Although it has been reported that 
anemia or polycythemia was associated with cardiovascular 
mortality (6, 7), the subsequent studies for general population 
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did not show any significant association between hemoglobin 
or hematocrit level and CVD mortality after adjustment of mul-
tiple cardiovascular risk factors (15, 16). A recent study in Nor-
way reported that elevated hemoglobin levels were associated 
with AMI only in men (17). In this study, we first showed the in-
dependent U-shape association between hemoglobin level and 
CVD incidence, including IHD and stroke in men. Furthermore, 
we demonstrated that even hemoglobin level within a normal 
range is related to CVD incidence in men.
 In this large cohort study, we were also able to confirm the 
differences in the CVD subtype between Asian and Western 
populations. In both men and women, stroke accounted for 
30% of overall CVD events, and hemorrhagic stroke accounted 
for 24% of overall stroke events. The results are consistent with 
those of the earlier studies (18, 19), and these proportions were 
much larger than in Western populations (20). Our results show-
ed both extreme hemoglobin levels were related to the higher 
stroke incidence, including those of ischemic and hemorrhagic 
origin, in men. In women, only higher hemoglobin level was 
related to higher stroke incidence.
 Our results showed a positive correlation between hemoglo-
bin level and well-known cardiovascular risk factors such as 
BMI, blood pressure, fasting glucose, total cholesterol, and smo-
king status after adjusting for age, and these results were con-
sistent with a previous study (21). After adjusting for these risk 
factors, low and high hemoglobin levels were independently 
associated with higher CVD incidence in men. 
 It is known that increased hemoglobin concentration or he-
matocrit level leads to increased blood viscosity, thereby raising 
peripheral resistance and reducing blood flow and perfusion 
(22). In addition, elevated hematocrit level may activate plate-
lets by releasing adenosine diphosphate (ADP) (23). Further-
more, high level of accumulated iron itself can increase cardio-
vascular risk by oxidative stress and lipid peroxidation (24). Ane-
mia or low hemoglobin levels could also negatively affect the 
cardiovascular system. Anemia contributes to the development 
of myocardial ischemia and left ventricular hypertrophy (25, 
26), and decreased hemoglobin levels were associated with high-
er plasma levels of fibrinogen in healthy men (27). In addition, 
low grade inflammation might contribute to decreased hemo-
globin levels and increased CVD incidence by the effect of pro-
inflammatory cytokines such as tumor necrosis factor α, inter-
feron-γ, interleukin-1, interleukin-6 (28, 29). 
 Gender differences in our results could be explained by the 
different hemoglobin levels between men and women. The 
mean hemoglobin level of 5th quintile in women was 14.4 g/
dL, which was lower than the mean hemoglobin level of 2nd 
quintile in men (14.7 g/dL). The hemoglobin level of most wo-
men might not be high enough to increase cardiovascular risk, 
and this might be an explanation for the lower cardiovascular 
risk in women than men. Interestingly, low hemoglobin levels 
were related to higher CVD incidence in men, but not in wom-
en despite much lower mean hemoglobin level in women than 
men. This gender difference could be explained by hormesis. 
In other words, repeated low hemoglobin status caused by mens-
truation might make the women’s cardiovascular system resis-
Table 4. Multivariable adjusted hazard ratios (HR) for cardiovascular disease by hemoglobin quintile in women*
Quintiles†
I II III IV IV
HR 95% CI HR 95% CI HR HR 95% CI HR 95% CI
Pre-menopausal women ( < 50 yr)
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
0.97
0.97
1.03
0.91
1.17
1.08
0.84-1.12
0.74-1.27
0.40-2.62
0.69-1.20
0.74-1.86
0.64-1.81
1.12
1.28
1.05
1.02
1.16
1.05
0.97-1.29
0.99-1.65
0.44-2.81
0.77-1.35
0.72-1.86
0.61-1.80
1.0
1.0
1.0
1.0
1.0
1.0
1.10
1.29
1.33
1.20
1.37
1.02
0.96-1.26
1.01-1.64
0.58-3.04
0.92-1.56
0.88-2.12
0.60-1.74
1.15
1.37
1.17
1.22
1.46
1.31
1.01-1.31
1.08-1.73
0.52-2.64
0.94-1.58
0.95-2.24
0.80-2.17
Post-menopausal women ( ≥ 50 yr)
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
1.07
1.21
1.09
1.08
1.10
1.02
0.98-1.17
1.05-1.40
0.75-1.58
0.92-1.25
0.90-1.34
0.74-1.40
0.98
0.98
0.96
1.04
1.04
0.99
0.90-1.06
0.85-1.14
0.66-1.38
0.90-1.20
0.85-1.26
0.72-1.35
1.0
1.0
1.0
1.0
1.0
1.0
1.03
0.98
0.75
1.06
1.14
1.11
0.95-1.11
086-1.12
0.52-1.06
0.93-1.22
0.96-1.36
0.84-1.46
1.08
0.89
0.87
1.14
1.15
1.12
1.01-1.16
0.79-1.01
0.63-1.19
1.00-1.29
0.97-1.35
0.86-1.45
All women
Total CVD
IHD
AMI
Stroke
Ischemic 
Hemorrhagic 
1.03
1.12
1.07
1.03
1.10
1.04
0.96-1.11
0.99-1.27
0.76-1.51
0.90-1.18
0.92-1.32
0.79-1.36
1.01
1.05
0.98
1.04
1.05
1.00
0.94-1.09
0.92-1.18
0.69-1.37
0.91-1.18
0.88-1.26
0.77-1.31
1.0
1.0
1.0
1.0
1.0
1.0
1.04
1.04
0.81
1.09
1.17
1.09
0.98-1.11
0.93-1.17
0.59-1.12
0.97-1.23
1.00-1.37
0.85-1.40
1.09
0.98
0.89
1.15
1.18
1.14
1.03-1.16
0.88-1.09
0.67-1.20
1.03-1.29
1.02-1.38
0.91-1.45
Hazard ratios and 95 percent confidence intervals for cardiovascular outcomes were estimated in Cox proportional hazards regression analysis. *Adjusted for age, body mass 
index, total cholesterol, serum creatinine, uric acid, WBC count, hypertension, diabetes mellitus, smoking status, alcohol drinking, and regular exercise; †The range of hemoglo-
bin quintiles: I (10-12.2 g/dL), II (12.3-12.7 g/dL), III (12.8-13.2 g/dL), IV (13.3-13.7 g/dL), and V (13.8-20 g/dL). HR, hazard ratio; CI, confidence interval; CVD, cardiovascular 
disease; IHD, ischemic heart disease; AMI, acute myocardial infarction. 
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tant to anemia or low hemoglobin concentration (30, 31). 
 Our study has several limitations. First, we did not measure 
CVD incidence by standard methods but based on the health 
insurance reimbursement data from the NHIC. However, previ-
ous validation results showed a relatively good accuracy rate of 
the data from the NHIC. The accuracy rate of the ICD codes for 
stroke according to the NHIC was reported as 83.0% in 2000 
(32). Second, our study was not based on a general population 
sample that could represent the Korean population. However, 
the large number of participants from 17 centers located throu-
ghout the country may lessen the potential selection bias. Third, 
red blood cell distribution width (RDW) has known to be relat-
ed to CVD mortality (33), and could be a potential confounding 
factor in this study. However we could not assess other hema-
tologic parameters such as RDW, mean corpuscular hemoglo-
bin, mean corpuscular hemoglobin concentration because 
KHS database did not include them. Finally, this observational 
study does not give information about whether a hemoglobin 
level is a modifiable cardiovascular risk factor or a simple pre-
dictor for CVD. 
 In conclusion, we found an independent U-shaped associa-
tion between hemoglobin level and CVD incidence, including 
IHD and stroke, in Korean men, and this association was also 
observed within the normal hemoglobin range. In the future, it 
is essential to investigate whether this association is applicable 
in other ethnic groups and whether active correction of minor 
hemoglobin variations can prevent future cardiovascular events.
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